Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octreotide in Primary Inoperable Thymoma
NCT00332969Phase 2Completed
- Sponsor
- Novartis
- Start
- Sep 2005
- Primary completion
- Oct 2010
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of octreotide in thymoma, sponsored by Novartis. Started Sep 2005; status: completed.
02
Drugs
octreotide
03
Conditions
thymoma
Beyond the preview
Go deeper on NCT00332969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00332969.